Singapore markets close in 1 hour 43 minutes

BioInvent International AB (publ) (BINV.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
30.60+1.05 (+3.55%)
As of 09:16AM CEST. Market open.
Currency in SEK

Valuation measures4

Market cap (intra-day) 1.94B
Enterprise value 901.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)31.81
Price/book (mrq)1.58
Enterprise value/revenue 14.74
Enterprise value/EBITDA -20.59

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 316.34%
S&P500 52-week change 328.04%
52-week high 330.60
52-week low 314.00
50-day moving average 321.16
200-day moving average 317.58

Share statistics

Avg vol (3-month) 376.46k
Avg vol (10-day) 381.44k
Shares outstanding 565.8M
Implied shares outstanding 665.8M
Float 832.82M
% held by insiders 113.36%
% held by institutions 154.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 314 Dec 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,509.91%

Management effectiveness

Return on assets (ttm)-15.88%
Return on equity (ttm)-23.92%

Income statement

Revenue (ttm)61.15M
Revenue per share (ttm)0.93
Quarterly revenue growth (yoy)-63.40%
Gross profit (ttm)N/A
EBITDA -369.22M
Net income avi to common (ttm)-334.52M
Diluted EPS (ttm)-5.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.06B
Total cash per share (mrq)16.17
Total debt (mrq)21.18M
Total debt/equity (mrq)1.72%
Current ratio (mrq)13.45
Book value per share (mrq)18.73

Cash flow statement

Operating cash flow (ttm)-328.67M
Levered free cash flow (ttm)-222.21M